Aberrant DNA methylation in cancer is involved in tumourigenesis, silencing of tumour suppressor genes, as well as evasion of tumour cells from immune surveillance by suppressing expression of MHC molecules and tumour antigens needed to induce an anti-tumour immune response (36–38). This evidence concerns the gene HLA-C and cancer.